Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer
Open Access
- 17 March 2023
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 128 (10) , 1862-1878
Abstract
Background: One-third of cancers activate endogenous synthesis of serine/glycine, and can become addicted to this pathway to sustain proliferation and survival. Mechanisms driving this metabolic rewiring remain largely unknown. Methods: NKX2–1 overexpressing and NKX2–1 knockdown/knockout T-cell leukaemia and lung cancer cell line models were established to study metabolic rewiring using ChIP-qPCR, immunoblotting, mass spectrometry, and proliferation and invasion assays. Findings and therapeutic relevance were validated in mouse models and confirmed in patient datasets. Results: Exploring T-cell leukaemia, lung cancer and neuroendocrine prostate cancer patient datasets highlighted the transcription factor NKX2–1 as putative driver of serine/glycine metabolism. We demonstrate that transcription factor NKX2–1 binds and transcriptionally upregulates serine/glycine synthesis enzyme genes, enabling NKX2–1 expressing cells to proliferate and invade in serine/glycine-depleted conditions. NKX2–1 driven serine/glycine synthesis generates nucleotides and redox molecules, and is associated with an altered cellular lipidome and methylome. Accordingly, NKX2–1 tumour-bearing mice display enhanced tumour aggressiveness associated with systemic metabolic rewiring. Therapeutically, NKX2–1-expressing cancer cells are more sensitive to serine/glycine conversion inhibition by repurposed anti-depressant sertraline, and to etoposide chemotherapy. Conclusion: Collectively, we identify NKX2–1 as a novel transcriptional regulator of serine/glycine synthesis addiction across cancers, revealing a therapeutic vulnerability of NKX2–1-driven cancers.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (1106121N, 1116822N, 1S14517N, G0A4220N, KAN2018 1501419N)
- Kom op tegen kanker (Stand up to Cancer), the Flemish cancer society (projectID: 13035).
- Stichting Tegen Kanker (project F/2020/1333, project F/2020/1333)
- KU Leuven (C14/18/104)
- KWF Kankerbestrijding (#13486)
This publication has 72 references indexed in Scilit:
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesisNature Genetics, 2011
- Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applicationsBioinformatics, 2011
- Serum triglyceride concentrations and cancer risk in a large cohort study in AustriaBritish Journal of Cancer, 2009
- Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerOncogene, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphomaGenes & Development, 2006
- The Human Genome Browser at UCSCGenome Research, 2002